Cargando…

A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis

BACKGROUND: Tumor necrosis factor-like weak inducer of apoptosis (Tnfsf12; TWEAK) and its receptor Fibroblast growth factor-inducible 14 (Tnfrsf12a; Fn14) participate in the inflammatory response associated with vascular remodeling. However, the functional effect of TWEAK on vascular smooth muscle c...

Descripción completa

Detalles Bibliográficos
Autores principales: Méndez-Barbero, Nerea, Gutierrez-Muñoz, Carmen, Madrigal-Matute, Julio, Mínguez, Pablo, Egido, Jesús, Michel, Jean-Baptiste, Martín-Ventura, Jose L., Esteban, Vanesa, Blanco-Colio, Luis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712059/
https://www.ncbi.nlm.nih.gov/pubmed/31395500
http://dx.doi.org/10.1016/j.ebiom.2019.07.072
_version_ 1783446613550694400
author Méndez-Barbero, Nerea
Gutierrez-Muñoz, Carmen
Madrigal-Matute, Julio
Mínguez, Pablo
Egido, Jesús
Michel, Jean-Baptiste
Martín-Ventura, Jose L.
Esteban, Vanesa
Blanco-Colio, Luis M.
author_facet Méndez-Barbero, Nerea
Gutierrez-Muñoz, Carmen
Madrigal-Matute, Julio
Mínguez, Pablo
Egido, Jesús
Michel, Jean-Baptiste
Martín-Ventura, Jose L.
Esteban, Vanesa
Blanco-Colio, Luis M.
author_sort Méndez-Barbero, Nerea
collection PubMed
description BACKGROUND: Tumor necrosis factor-like weak inducer of apoptosis (Tnfsf12; TWEAK) and its receptor Fibroblast growth factor-inducible 14 (Tnfrsf12a; Fn14) participate in the inflammatory response associated with vascular remodeling. However, the functional effect of TWEAK on vascular smooth muscle cells (VSMCs) is not completely elucidated. METHODS: Next generation sequencing-based methods were performed to identify genes and pathways regulated by TWEAK in VSMCs. Flow-citometry, wound-healing scratch experiments and transwell migration assays were used to analyze VSMCs proliferation and migration. Mouse wire injury model was done to evaluate the role of TWEAK/Fn14 during neointimal hyperplasia. FINDINGS: TWEAK up-regulated 1611 and down-regulated 1091 genes in VSMCs. Using a gene-set enrichment method, we found a functional module involved in cell proliferation defined as the minimal network connecting top TWEAK up-regulated genes. In vitro experiments in wild-type or Tnfrsf12a deficient VSMCs demonstrated that TWEAK increased cell proliferation, VSMCs motility and migration. Mechanistically, TWEAK increased cyclins (cyclinD1), cyclin-dependent kinases (CDK4, CDK6) and decreased cyclin-dependent kinase inhibitors (p15(lNK4B)) mRNA and protein expression. Downregulation of p15(INK4B) induced by TWEAK was mediated by mitogen-activated protein kinase ERK and Akt activation. Tnfrsf12a or Tnfsf12 genetic depletion and pharmacological intervention with TWEAK blocking antibody reduced neointimal formation, decreasing cell proliferation, cyclin D1 and CDK4/6 expression, and increasing p15(INK4B) expression compared with wild type or IgG-treated mice in wire-injured femoral arteries. Finally, immunohistochemistry in human coronary arteries with stenosis or in-stent restenosis revealed high levels of Fn14, TWEAK and PCNA in VSMCs enriched areas of the neointima as compared with healthy coronary arteries. INTERPRETATION: Our data define a major role of TWEAK/Fn14 in the control of VSMCs proliferation and migration during neointimal hyperplasia after wire injury in mice, and identify TWEAK/Fn14 as a potential target for treating in-stent restenosis. FUND: ISCiii-FEDER, CIBERCV and CIBERDEM.
format Online
Article
Text
id pubmed-6712059
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67120592019-08-29 A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis Méndez-Barbero, Nerea Gutierrez-Muñoz, Carmen Madrigal-Matute, Julio Mínguez, Pablo Egido, Jesús Michel, Jean-Baptiste Martín-Ventura, Jose L. Esteban, Vanesa Blanco-Colio, Luis M. EBioMedicine Research paper BACKGROUND: Tumor necrosis factor-like weak inducer of apoptosis (Tnfsf12; TWEAK) and its receptor Fibroblast growth factor-inducible 14 (Tnfrsf12a; Fn14) participate in the inflammatory response associated with vascular remodeling. However, the functional effect of TWEAK on vascular smooth muscle cells (VSMCs) is not completely elucidated. METHODS: Next generation sequencing-based methods were performed to identify genes and pathways regulated by TWEAK in VSMCs. Flow-citometry, wound-healing scratch experiments and transwell migration assays were used to analyze VSMCs proliferation and migration. Mouse wire injury model was done to evaluate the role of TWEAK/Fn14 during neointimal hyperplasia. FINDINGS: TWEAK up-regulated 1611 and down-regulated 1091 genes in VSMCs. Using a gene-set enrichment method, we found a functional module involved in cell proliferation defined as the minimal network connecting top TWEAK up-regulated genes. In vitro experiments in wild-type or Tnfrsf12a deficient VSMCs demonstrated that TWEAK increased cell proliferation, VSMCs motility and migration. Mechanistically, TWEAK increased cyclins (cyclinD1), cyclin-dependent kinases (CDK4, CDK6) and decreased cyclin-dependent kinase inhibitors (p15(lNK4B)) mRNA and protein expression. Downregulation of p15(INK4B) induced by TWEAK was mediated by mitogen-activated protein kinase ERK and Akt activation. Tnfrsf12a or Tnfsf12 genetic depletion and pharmacological intervention with TWEAK blocking antibody reduced neointimal formation, decreasing cell proliferation, cyclin D1 and CDK4/6 expression, and increasing p15(INK4B) expression compared with wild type or IgG-treated mice in wire-injured femoral arteries. Finally, immunohistochemistry in human coronary arteries with stenosis or in-stent restenosis revealed high levels of Fn14, TWEAK and PCNA in VSMCs enriched areas of the neointima as compared with healthy coronary arteries. INTERPRETATION: Our data define a major role of TWEAK/Fn14 in the control of VSMCs proliferation and migration during neointimal hyperplasia after wire injury in mice, and identify TWEAK/Fn14 as a potential target for treating in-stent restenosis. FUND: ISCiii-FEDER, CIBERCV and CIBERDEM. Elsevier 2019-08-05 /pmc/articles/PMC6712059/ /pubmed/31395500 http://dx.doi.org/10.1016/j.ebiom.2019.07.072 Text en © 2019 The Authors. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research paper
Méndez-Barbero, Nerea
Gutierrez-Muñoz, Carmen
Madrigal-Matute, Julio
Mínguez, Pablo
Egido, Jesús
Michel, Jean-Baptiste
Martín-Ventura, Jose L.
Esteban, Vanesa
Blanco-Colio, Luis M.
A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
title A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
title_full A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
title_fullStr A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
title_full_unstemmed A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
title_short A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
title_sort major role of tweak/fn14 axis as a therapeutic target for post-angioplasty restenosis
topic Research paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712059/
https://www.ncbi.nlm.nih.gov/pubmed/31395500
http://dx.doi.org/10.1016/j.ebiom.2019.07.072
work_keys_str_mv AT mendezbarberonerea amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT gutierrezmunozcarmen amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT madrigalmatutejulio amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT minguezpablo amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT egidojesus amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT micheljeanbaptiste amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT martinventurajosel amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT estebanvanesa amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT blancocolioluism amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT mendezbarberonerea majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT gutierrezmunozcarmen majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT madrigalmatutejulio majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT minguezpablo majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT egidojesus majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT micheljeanbaptiste majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT martinventurajosel majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT estebanvanesa majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis
AT blancocolioluism majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis